Keywords: -salix, pharmaceuticals, license, lafutidine, salix, signed, letter

-Salix Pharmaceuticals to license lafutidine

Article | 04 March 1999

- Salix Pharmaceuticals has signed a letter of intent to licenseexclusive worldwide rights to Fujirebio's antiulcer drug lafutidine which is currently ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Salix Pharmaceuticals

Go to company listing